These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9184380)

  • 1. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines.
    Li Z
    Semin Immunol; 1997 Oct; 9(5):315-22. PubMed ID: 9327526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.
    Srivastava PK; Jaikaria NS
    Methods Mol Biol; 2001; 156():175-86. PubMed ID: 11068759
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous heat shock protein-peptide complexes for vaccination against cancer: from bench to bedside.
    Hoos A; Levey DL; Lewis JJ
    Dev Biol (Basel); 2004; 116():109-15; discussion 133-43. PubMed ID: 15603187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel therapeutic fusion protein vaccine by two different families of heat shock proteins linked with HPV16 E7 generates potent antitumor immunity and antiangiogenesis.
    Liu B; Ye D; Song X; Zhao X; Yi L; Song J; Zhang Z; Zhao Q
    Vaccine; 2008 Mar; 26(10):1387-96. PubMed ID: 18272260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-shock protein-based vaccines for cancer and infectious disease.
    Binder RJ
    Expert Rev Vaccines; 2008 Apr; 7(3):383-93. PubMed ID: 18393608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock proteins as vaccine adjuvants in infections and cancer.
    Segal BH; Wang XY; Dennis CG; Youn R; Repasky EA; Manjili MH; Subjeck JR
    Drug Discov Today; 2006 Jun; 11(11-12):534-40. PubMed ID: 16713905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat-shock proteins as powerful weapons in vaccine development.
    Bolhassani A; Rafati S
    Expert Rev Vaccines; 2008 Oct; 7(8):1185-99. PubMed ID: 18844593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein vaccines: from bench to bedside.
    Binder RJ
    Int Rev Immunol; 2006; 25(5-6):353-75. PubMed ID: 17169780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents.
    Srivastava PK; Amato RJ
    Vaccine; 2001 Mar; 19(17-19):2590-7. PubMed ID: 11257397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications.
    Hoos A; Levey DL
    Expert Rev Vaccines; 2003 Jun; 2(3):369-79. PubMed ID: 12903802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of heat shock protein-peptide complexes on tumor and infectious diseases immunity].
    Meng SD; Gao F; Tien P
    Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):425-8. PubMed ID: 11051811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
    Ménoret A; Chandawarkar R
    Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune activity of heat shock protein gp96 and its application in active immunotherapy for tumor and infectious diseases].
    Xu Y; Wang S; Zhang X; Meng S
    Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):261-6. PubMed ID: 22712385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of heat shock proteins in tumor immunity.
    Li Z
    Cancer Chemother Biol Response Modif; 2001; 19():371-83. PubMed ID: 11686024
    [No Abstract]   [Full Text] [Related]  

  • 18. Recent advances in heat shock protein-based cancer vaccines.
    Wang HH; Mao CY; Teng LS; Cao J
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):22-7. PubMed ID: 16481277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gp96-peptide vaccination of mice against intracellular bacteria.
    Zügel U; Sponaas AM; Neckermann J; Schoel B; Kaufmann SH
    Infect Immun; 2001 Jun; 69(6):4164-7. PubMed ID: 11349093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step single-chain Fv recombinant antibody-based purification of gp96 for vaccine development.
    Arnold-Schild D; Kleist C; Welschof M; Opelz G; Rammensee HG; Schild H; Terness P
    Cancer Res; 2000 Aug; 60(15):4175-8. PubMed ID: 10945626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.